AGF U.S. Market Neutral Anti-Beta Fund (BTAL)
| Assets | $379.51M |
| Expense Ratio | 1.43% |
| PE Ratio | 15.79 |
| Shares Out | 19.60M |
| Dividend (ttm) | $1.04 |
| Dividend Yield | 5.48% |
| Ex-Dividend Date | Dec 27, 2023 |
| Payout Ratio | 86.61% |
| 1-Year Return | -7.00% |
| Volume | 231,784 |
| Open | 19.16 |
| Previous Close | 19.20 |
| Day's Range | 18.94 - 19.17 |
| 52-Week Low | 16.59 |
| 52-Week High | 21.30 |
| Beta | -0.54 |
| Holdings | 405 |
| Inception Date | Sep 13, 2011 |
About BTAL
Fund Home PageThe AGF U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long/short alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is issued by AGF.
Top 10 Holdings
112.89% of assets| Name | Symbol | Weight |
|---|---|---|
| Cash | n/a | 104.41% |
| Portfolio Swap Dow Jones Thematic Neu Anti-Beta | n/a | 2.69% |
| MicroStrategy Incorporated | MSTR | 1.47% |
| BILL Holdings, Inc. | BILL | 0.71% |
| Interactive Brokers Group, Inc. | IBKR | 0.64% |
| Sprouts Farmers Market, Inc. | SFM | 0.61% |
| Paycom Software, Inc. | PAYC | 0.59% |
| LPL Financial Holdings Inc. | LPLA | 0.59% |
| HealthEquity, Inc. | HQY | 0.59% |
| Confluent, Inc. | CFLT | 0.59% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 27, 2023 | $1.041 | Jan 2, 2024 |
| Dec 28, 2022 | $0.213 | Jan 3, 2023 |
| Dec 27, 2019 | $0.196 | Jan 3, 2020 |
| Dec 27, 2018 | $0.086 | Jan 3, 2019 |
| Sep 14, 2012 | $0.001 | Sep 21, 2012 |
| Dec 20, 2011 | $0.427 | Dec 28, 2011 |
News
BTAL: A Wonderful ETF For Bear Markets
BTAL is an ETF with a 1.72% total expense ratio, negative long-term returns, and is down most years. Its design is crazy, like a fox. BTAL is a market-neutral fund designed to perform well only in bea...
BTAL Is Possibly The Most Misunderstood Market-Neutral ETF
BTAL is an anti-beta market-neutral ETF, not beta-neutral, with imbalanced long and short positions. High-beta stocks fall further in market crashes, underperform in calm markets, and perform well aft...
BTAL Anti-Beta Fund: Still A Great Diversifier
The AGF U.S. Market Neutral Anti-Beta Fund has historically provided diversification benefits by performing well when the broader equity market is down. Despite its expected flat-to-negative annual re...
BTAL: A Smart Way To Hedge The Market
BTAL is a hedging exchange-traded fund that takes a market-neutral stance by shorting high beta names and going long low beta equities. The fund makes money when the market is in a risk-off mode and p...
BTAL: A Great Buy, But Not For The Obvious Reason
BTAL's main objective is to act as a hedge to stocks that can be valuable during times of market distress. While now may be a good time to own BTAL, the benefits of the ETF go beyond the potential suc...
BTAL: Buy While Financial Conditions Are Tightening
The BTAL fund is an actively managed ETF that provides exposure to the spread between low beta and high beta stocks. The low beta/high beta spread is highly correlated to financial conditions.
4 ETFs To Bet On Falling Equities
Shorting equity markets generally has historically been a high-risk proposition, but the risk of significant and protracted downturns is currently very high. Four ETFs, SH, TAIL, DWSH, and BTAL are ex...
BTAL: Underappreciated Alpha Producer
Producing market-beating returns per unit of risk is hard. The AGFiQ U.S. Market Neutral Anti-Beta Fund may help an investor to achieve this goal. BTAL goes long low beta stocks like H&R Block and Dol...
ETF Odds & Ends: WisdomTree Adds Battery Fund
Beyond launches, the week featured new closures and changes to several existing funds.
Preparing For The Next Downturn
Preparing For The Next Downturn
ETF Portfolio Hedging Strategy #2: Turning Beta Into Anti-Beta With BTAL
ETF Portfolio Hedging Strategy #2: Turning Beta Into Anti-Beta With BTAL
